|
|
|
|
A pill designed to zero in on abnormal genes that drive specific cancers has produced encouraging early results in children with an uncommon but aggressive type of lymphoma, as well as in children with a rare form of neuroblastoma.
A phase 1 clinical trial of the drug crizotinib achieved remissions, with minimal side effects, for 10 of the children participating in a clinical study carried out by the multicenter Children’s Oncology Group (COG). The results were “an exciting proof-of-principle” for the targeted treatment, said the study leader, Yaël P. Mossé, M.D., a pediatric oncologist at The Children’s Hospital of Philadelphia.
“We are entering a new era of cancer therapy, in which we use knowledge of basic biology to design very specific drugs that target cancer cells with potentially less side effects on healthy tissue,” said Mossé. “In addition, as we concentrate on targets in molecular pathways, we move away from an exclusive focus on one form of cancer to customizing treatments according to biological activity. Abnormal ALK activity occurs in subtypes of neuroblastoma and subtypes of lymphoma, so identifying ALK activity in individual patients may enable us to provide the most effective care.”
To view Multimedia News Release, go to http://www.multivu.com/mnr/50776-childrens-hospital-philadelphia-lymphoma-neuroblastoma-oncology-gene-trial
Runtime: 4m41s
Views: 5059 |
Comments: 0
|
|
|
|
|
Having a confident smile is important at any age, even more so when you grow up in the spotlight and need to be close-up ready at any moment. In search of a picture perfect smile, many young stars are turning to modern new options that straighten their teeth.
Today, treatment can take place with Invisalign - a clear and removable option that allows teeth-straightening to go nearly unnoticed because the braces are virtually invisible. A series of clear aligners move teeth gradually over time. Gone are the days when straightening teeth means you have to wear metal braces and deal with all the challenges associated with them.
To view Multimedia News Release, go to http://www.multivu.com/players/English/53352-invisalign-secret-to-hollywood-smiles/
Runtime: 2m3s
Views: 6112 |
Comments: 0
|
|
|
|
|
http://LongPathTool.com Long Path Tool fixes path too long error allowing to delete or copy long path files or files locked by other applications. Long Path Tool can fix: Path too long. Error cannot delete file: cannot read from source file or disk. Cannot delete file: Access is denied. There has been a sharing violation. Cannot delete file or folder The file name you specified is not valid or too long. Specify a different file name. The source or destination file may be in use. The file is in use by another program or user. Error Deleting File or Folder. Make sure the disk is not full or write-protected and that the file is not currently in use. Path too deep.
Runtime: 3m31s
Views: 5602 |
Comments: 0
|
|
|
|
|
Click: http://jenavive.com
Jenavive performing Mechanical Boy. © 2014 Blackstream Records
Director: David Fyfe
Producer: Airgead
Production Company: Fyfedawg Productions
Make up and Costume: Carbon MUFX
Mechanical Boy played by Rex Cable
Runtime: 3m55s
Views: 1424 |
Comments: 0
|
|
|
|
|
ast
Runtime: 1m59s
Views: 7642 |
Comments: 0
|
|
|
|
|
ast
Runtime: 0m31s
Views: 3585 |
Comments: 0
|
|
|
|
|
ast
Runtime: 0m30s
Views: 3616 |
Comments: 0
|
|
|
|
|
ast
Runtime: 0m52s
Views: 3575 |
Comments: 0
|
|
|
|
|
ast
Runtime: 0m50s
Views: 3792 |
Comments: 0
|
|
|
|
|
Moms have been after their kids for years. Doctors, nutritionists, the government and gurus hound us but still, most Americans don’t eat enough vegetables. A recent Centers for Disease Control study shows no U.S. state is meeting the objectives for vegetable consumption. Now, Green Giant™ is introducing a simple solution: NEW Green Giant™ Veggie Blend-Ins™ 100% Carrot Purée, 100% Spinach Purée and 100% Butternut Squash Purée.
To view Multimedia News Release, go to http://www.multivu.com/mnr/65725-general-mills-green-giant-veggie-blend-ins-jessica-seinfeld-vegout-purees
Runtime: 1m7s
Views: 2436 |
Comments: 0
|
|
|
|
|
Upsher-Smith Laboratories, Inc. [http://www.upsher-smith.com] today announced that its epilepsy-focused educational website, http://www.Epilog.us, has been expanded to include thought-leader commentary on issues related to Epilepsy and Comorbidities. The newly updated website will make its debut at the 64th Annual American Academy of Neurology Meeting in New Orleans on April 23 – 26, 2012, at the Upsher-Smith exhibit, booth number 128.
TO view Multimedia News Release, go to http://www.multivu.com/mnr/55934-upsher-smith-expands-epilog-us-on-epilepsy-comorbidities
Runtime: 7m8s
Views: 4859 |
Comments: 0
|
|
|
|
|
a slideshow of my abstract photographs
Runtime: 6m8s
Views: 10557 |
Comments: 0
|
